MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Epidemiology worldwide.
Home SERVICES Questionnaire Licensing
DSM (Diabetes Symptom Measure)

Developed by:
Novo Nordisk (Denmark)

Objective:
To measure the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience

Copyright:
© Novo Nordisk, 2006. All rights reserved.

Reference publication:
Meryl Brod, Soren E. Skovlund & Kim U. Wittrup-Jensen. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Quality of Life Research (2006) 15: 481–491.
 

Conditions of use:

1. User Agreement:

User is required to complete and sign a User Agreement in which specific conditions requested by the Author are detailed.

2. Access fees:

carre6 Author's royalty fee: 

- In academic research and individual clinical practice: free of charge

- In commercial studies: 500 €* per study and per available language-version requested.

Other specific conditions requested by the Author are detailed in the User Agreement.

carre6 Distribution fees are requested according to the study design and context of use of the questionnaire:
 
- In not-funded academic research (1) and individual clinical practice: free of charge

- In funded academic research (2): 300 €* per study + 50 €* per language version

- In commercial studies (3) involving "for-profit" organizations: 600 €* per study + 250 €* per language version

* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies).


Review copy:

US English version available for review purpose only. Please click here to access.


Contact information:

MAPI Research Trust

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 55 73
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.

More information on DSM on PROQOLID

[ BACK ]
 

To access our catalog, please click here.

New questionnaires distributed by MAPI Research Trust

ACCEPT (Chronic Treatment Acceptance Questionnaire)
MAPI SAS / Registrat MAPI (France)

ADRQL (Alzheimer Disease Related Quality of Life)
Black Betty S, Kasper Judith D and Rabins Peter V. - Johns Hopkins Medical INstitutions (USA)

Barthel Index questionnaire
The Maryland State Medical Society - MedChi (USA)

ESS (Epworth Sleepiness Scale) 
Murray W. Johns (Australia)

FIRST (Fibromyalgia Rapid Screening Tool)
Serge Perrot & Didier Bouhassira (France)

PDSS-2 (Parkinson's Disease Sleep Scale)
Ray Chaudhuri (UK) & Claudia Trenkwalder (Germany)

Skindex questionnaire 
Mary-Margaret Chren (USA)

TRIM-D and TRIM-D Device (Treatment Related Impact Measure for Diabetes)
Novo Nordisk (Denmark)